Butyltriphenylphosphonium

Butyltriphenylphosphonium

SCHEMBL3418099

CCCC[P+](c1ccccc1)(c1ccccc1)c1ccccc1.[OH-]

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQ

The experimentally established mechanism targets of Butyltriphenylphosphonium. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 1/20 0.61
ALDH1A1 P00352 2/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2D6 P10635 1/20 0.47
TSHR P16473 1/20 0.47
CYP2C19 P33261 1/20 0.47
CHRNA7 P36544 8/20 0.42
TRAP1 Q12931 2/20 0.41
CNR2 P34972 1/20 0.40
MEN1 O00255 1/20 0.39
MAPT P10636 1/20 0.39
MAPK1 P28482 1/20 0.39
KMT2A Q03164 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
POLB P06746 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Butyltriphenylphosphonium SCHEMBL30358591 0.98 HIF1A (0.64) HIF1AALDH1A1CYP1A2CYP2D6TSHR
Butyltriphenylphosphonium SCHEMBL584744 0.95 HIF1A (0.61) HIF1AALDH1A1CYP1A2CYP2D6TSHR
Butyltriphenylphosphonium SCHEMBL8535782 0.95 HIF1A (0.61) HIF1AALDH1A1CYP1A2CYP2D6TSHR
Butyltriphenylphosphonium SCHEMBL159490 0.95 HIF1A (0.61) HIF1AALDH1A1CYP1A2CYP2D6TSHR
Butyltriphenylphosphonium SCHEMBL584160 0.95 HIF1A (0.61) HIF1AALDH1A1CYP1A2CYP2D6TSHR
Butyltriphenylphosphonium SCHEMBL1063 0.95 HIF1A (0.61) HIF1AALDH1A1CYP1A2CYP2D6TSHR
Butyltriphenylphosphonium SCHEMBL7865507 0.93 HIF1A (0.58) HIF1AALDH1A1CYP1A2CYP2D6TSHR
Butyltriphenylphosphonium SCHEMBL2650050 0.93 HIF1A (0.58) HIF1AALDH1A1CYP1A2CYP2D6TSHR
Butyltriphenylphosphonium SCHEMBL28007945 0.93 HIF1A (0.58) HIF1AALDH1A1CYP1A2CYP2D6TSHR
Water SCHEMBL7695338 0.93 HIF1A (0.58) HIF1AALDH1A1CYP1A2CYP2D6TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116120519-A Refining method of ultra-high purity epoxy resin 惠柏新材料科技(上海)股份有限公司 2023-05-16 CN claimed
CN-108192075-A Method for refining ultrahigh-purity epoxy resin 惠柏新材料科技(上海)股份有限公司 2018-06-22 CN claimed
US-20130161840-A1 STRIPPER SOLUTIONS EFFECTIVE FOR BACK-END-OF-LINE OPERATIONS DYNALOY LLC (US) 2013-06-27 US claimed
US-8440389-B2 Stripper solutions effective for back-end-of-line operations DYNALOY, LLC (US) 2013-05-14 US claimed
US-20100221503-A1 STRIPPER SOLUTIONS EFFECTIVE FOR BACK-END-OF-LINE OPERATIONS DYNALOY LLC (US) 2010-09-02 US claimed
WO-2010008877-A1 STRIPPER SOLUTIONS EFFECTIVE FOR BACK-END-OF LINE OPERATIONS DYNALOY LLC (US) 2010-01-21 WO claimed
US-6316575-B1 MELT TRANSESTERIFICATION OF DIOL COMPOUND AND CARBOANTE COMPOUND USING CATALYST COMPRISING A PHOSPHORUS-CONTAINING BASIC COMPOUND QUATERNARY PHOSPHONIUM SALT TO FORM POLYCARBONATE IDEMITSU KOSAN CO., LTD. (JP) 2001-11-13 US claimed
EP-0673959-B1 Process for producing aromatic polycarbonate MITSUBISHI CHEM CORP (JP) 1998-10-28 EP claimed
US-5527875-A Process for producing aromatic polycarbonate MITSUBISHI CHEMICAL CORPORATION (JP) 1996-06-18 US claimed
EP-0673959-A1 Process for producing aromatic polycarbonate Mitsubishi Chemical Corporation (JP) 1995-09-27 EP claimed
US-12522632-B2 Method for extracting keratin from wool/natural fibers using ionic liquids reinforced with sonication Najran University (SA) 2026-01-13 US disclosed
US-12460019-B2 Preparation of regenerated polysaccharides UNIVERSITAET ROSTOCK (DE) 2025-11-04 US disclosed
CN-115175943-B Preparation of regenerated polysaccharide 罗斯托克大学 2024-12-17 CN disclosed
US-20240309240-A1 POLISHING COMPOSITION, POLISHING METHOD, AND METHOD FOR PRODUCING SEMICONDUCTOR SUBSTRATE FUJIMI INCORPORATED (JP) 2024-09-19 US disclosed
US-20240239837-A1 METHOD FOR EXTRACTING KERATIN FROM WOOL/NATURAL FIBERS USING IONIC LIQUIDS REINFORCED WITH SONICATION Najran University (SA) 2024-07-18 US disclosed
EP-0673959-A1 Process for producing aromatic polycarbonate Mitsubishi Chemical Corporation (JP) 1995-09-27 EP disclosed
US-4395574-A Phosphonium phenoxide catalysts for promoting reaction of epoxides with phenols and/or carboxylic acids THE DOW CHEMICAL CO. (US) 1983-07-26 US disclosed
EP-0019852-B1 PHOSPHONIUM PHENOXIDE CATALYSTS, EPOXY RESIN CONTAINING SAME AND PROCESS FOR PROMOTING REACTION OF EPOXIDES WITH PHENOLS AND/OR CARBOXYLIC ACIDS THE DOW CHEMICAL COMPANY (US) 1983-07-20 EP disclosed
US-4302574-A Phosphonium phenoxide catalysts for promoting reacting of epoxides with phenols and/or carboxylic acids THE DOW CHEMICAL COMPANY (US) 1981-11-24 US disclosed
EP-0019852-A1 Phosphonium phenoxide catalysts, epoxy resin containing same and process for promoting reaction of epoxides with phenols and/or carboxylic acids THE DOW CHEMICAL COMPANY (US) 1980-12-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240239837-A1 METHOD FOR EXTRACTING KERATIN FROM WOOL/NATURAL FIBERS USING IONIC LIQUIDS REINFORCED WITH SONICATION KRT18, CKAP4, ANKK1 HIF1A 4183/4885ALDH1A1 4534/4885CYP1A2 4285/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.